It's third time out for molnupiravir, with the preliminary results of the Panoramic study. Does molnupiravir work at preventing admission to hospital? Does Panoramic support the findings of Move-Out? How directly linked to our patients are the two trials? What on Earth is a Bayesian credible interval? There's a lot to cover in just over 8 minutes!
